Eurosurveillance remains in the updated list of the Directory of Open Access Journals (DOAJ). It was first added to the DOAJ on 9 September 2004. Eurosurveillance is also listed in the Securing a Hybrid Environment for Research Preservation and Access / Rights MEtadata for Open archiving (SHERPA/RoMEO) [2], a database which uses a colour‐coding scheme to classify publishers according to their self‐archiving policy and to show the copyright and open access self-archiving policies of academic journals. Eurosurveillance is listed there as a ‘green’ journal, which means that authors can archive pre-print (i.e. pre-refereeing), post-print (i.e. final draft post-refereeing) and archive the publisher's version/PDF.

ESCAIDE participants are invited to the fifth Eurosurveillance scientific seminar on 30 November 2016

Follow Eurosurveillance on Twitter: @Eurosurveillanc

Read our articles on Zika virus infection

Read our articles on mcr-1-mediated colistin resistance

Note of concern published for 'Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015',

In this issue

Home Eurosurveillance Edition  2013: Volume 18/ Issue 47 Article 6
Back to Table of Contents
Previous Download (pdf)

Eurosurveillance, Volume 18, Issue 47, 21 November 2013
Special Eurobarometer: Use of antibiotics declining in the European Union but much work still needed
  1. European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden

Citation style for this article: Eurosurveillance editorial team. Special Eurobarometer: Use of antibiotics declining in the European Union but much work still needed. Euro Surveill. 2013;18(47):pii=20641. Available online:

According to the Special Eurobarometer 407, ‘Antimicrobial resistance’ published in November 2013, most Europeans (84%) are aware that the overuse of antibiotics makes them ineffective [1].  However, the general knowledge of Europeans about antibiotics remains quite low and results in the misuse of these drugs. When asked questions about antibiotics and how they work, 49% of respondents replied that antibiotics kill viruses whereas 40% correctly replied that antibiotics do not kill viruses. More than one in ten (11%) could not answer the question. Only slightly more than half of those polled (52%) could reply correctly that antibiotics are not* effective against colds and influenza. Most respondents (66%) are aware that the use of antibiotics can cause side-effects but nearly one fifth (19%) cannot answer the question. The above responses illustrate the challenge of those who try to make Europeans have a more prudent attitude towards antibiotic use.

The survey concludes that media campaigns are efficient sources of information but that they need to be targeted better in order to reach the desired audience and that the public regard healthcare workers and pharmacies as trusted sources of information for advising on the proper use of antibiotics.

The Eurobarometer is an instrument used by the European Commission to map public opinion in the European Union (EU). The standard Eurobarometer is based on about 1,000 face-to-face interviews per Member State and reports are published twice a year. Special Eurobarometer reports such as the above are based on in-depth thematical studies [2].

The 2013 Special Eurobarometer used the same questions and addressed the same objectives as a previous one published in 2010 [3]. It aimed to:

  • map the use of antibiotics in the EU: how often users took them, how they were obtained and why they were taken;
  • measure how much the public knows about the effectiveness of antibiotics and the risks linked to their inappropriate use
  • determine the impact of antibiotic awareness campaigns.

Encouraging findings are that the use of antibiotics has declined among respondents who reported having taken antibiotics in the last 12 months from 40% in 2009 to 35% in 2013; still there is a two-fold difference in this percentage among EU countries The large majority of those who used antibiotics in the time covered by the survey got them from a healthcare provider but 3 % of users obtained them without prescription. Antimicrobial resistance represents a serious threat to public health and patient safety and is a worldwide problem [4]. 

The European Antibiotic Awareness Day (EAAD) is a European health initiative, coordinated by the European Centre for Disease Prevention and Control (ECDC) since 2008, which aims to provide a platform and support for national campaigns on the prudent use of antibiotics. The European Commission adopted an ‘Action plan against the rising threats against Antimicrobial Resistance’ in 2011 [5]. One important aim of the action plan is to conduct research about effective ways to fight antimicrobial resistance and to ensure that antimicrobials are used appropriately.

* Erratum: The sentence 'Only slightly more than half of those polled (52%) could reply correctly that antibiotics are not* effective against colds and influenza.' was corrected on 22 November 2013. 


  1. European Commission. Special Eurobarometer 407 ‘Antimicrobial resistance’. TNS Opinion &Social, at the request of the European Commission, Directorate-General for Health and Consumers. 2013. Available from:
  2. European Commission. Public Opinion. Available from:
  3. European Commission. Special Eurobarometer 338 ‘Antimicrobial resistance’. Survey commissioned by the Directorate-General for Health and Consumers and coordinated by the Directorate-General Communication (“Research and Political Analysis” Unit).  2010. Available from
  4. Eurosurveillance editorial team. CDC publishes report on antibiotic resistance threats in the United States for the first time. Euro Surveill. 2013;18(38):pii=20588. Available online:
  5. Communication from the Commission to the European Parliament and the Council. Action plan Against the rising threats from Antimicrobial Resistance. Available from: 

Back to Table of Contents
Previous Download (pdf)

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN 1560-7917] - ©2007-2016. All rights reserved.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.